TY - JOUR
T1 - Genome-wide analysis of glucocorticoid-responsive transcripts in the hypothalamic paraventricular region of male rats
AU - Itoi, Keiichi
AU - Motoike, Ikuko
AU - Liu, Ying
AU - Clokie, Sam
AU - Iwasaki, Yasumasa
AU - Uchida, Katsuya
AU - Sato, Tatsuya
AU - Aguilera, Greti
N1 - Funding Information:
Financial Support: This work was supported by the Intramural Research Program of the National Institute of Child Health and Human Development of the National Institutes of Health (to G.A.), and Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research (Grant JP18K08499 to K.I.).
Publisher Copyright:
© 2019 Endocrine Society.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Glucocorticoids (GCs) are essential for stress adaptation, acting centrally and in the periphery. Corticotropin-releasing factor (CRF), a major regulator of adrenal GC synthesis, is produced in the paraventricular nucleus of the hypothalamus (PVH), which contains multiple neuroendocrine and preautonomic neurons. GCs may be involved in diverse regulatory mechanisms in the PVH, but the target genes of GCs are largely unexplored except for the CRF gene (Crh), a well-known target for GC negative feedback. Using a genome-wide RNA-sequencing analysis, we identified transcripts that changed in response to either high-dose corticosterone (Cort) exposure for 12 days (12-day high Cort), corticoid deprivation for 7 days (7-day ADX), or acute Cort administration. Among others, canonical GC target genes were upregulated prominently by 12-day high Cort. Crh was upregulated or downregulated most prominently by either 7-day ADX or 12-day high Cort, emphasizing the recognized feedback effects of GC on the hypothalamic-pituitary-adrenal (HPA) axis. Concomitant changes in vasopressin and apelin receptor gene expression are likely to contribute to HPA repression. In keeping with the pleotropic cellular actions of GCs, 7-day ADX downregulated numerous genes of a broad functional spectrum. The transcriptome response signature differed markedly between acute Cort injection and 12-day high Cort. Remarkably, six immediate early genes were upregulated 1 hour after Cort injection, which was confirmed by quantitative reverse transcription PCR and semiquantitative in situ hybridization. This study may provide a useful database for studying the regulatory mechanisms of GC-dependent gene expression and repression in the PVH.
AB - Glucocorticoids (GCs) are essential for stress adaptation, acting centrally and in the periphery. Corticotropin-releasing factor (CRF), a major regulator of adrenal GC synthesis, is produced in the paraventricular nucleus of the hypothalamus (PVH), which contains multiple neuroendocrine and preautonomic neurons. GCs may be involved in diverse regulatory mechanisms in the PVH, but the target genes of GCs are largely unexplored except for the CRF gene (Crh), a well-known target for GC negative feedback. Using a genome-wide RNA-sequencing analysis, we identified transcripts that changed in response to either high-dose corticosterone (Cort) exposure for 12 days (12-day high Cort), corticoid deprivation for 7 days (7-day ADX), or acute Cort administration. Among others, canonical GC target genes were upregulated prominently by 12-day high Cort. Crh was upregulated or downregulated most prominently by either 7-day ADX or 12-day high Cort, emphasizing the recognized feedback effects of GC on the hypothalamic-pituitary-adrenal (HPA) axis. Concomitant changes in vasopressin and apelin receptor gene expression are likely to contribute to HPA repression. In keeping with the pleotropic cellular actions of GCs, 7-day ADX downregulated numerous genes of a broad functional spectrum. The transcriptome response signature differed markedly between acute Cort injection and 12-day high Cort. Remarkably, six immediate early genes were upregulated 1 hour after Cort injection, which was confirmed by quantitative reverse transcription PCR and semiquantitative in situ hybridization. This study may provide a useful database for studying the regulatory mechanisms of GC-dependent gene expression and repression in the PVH.
UR - http://www.scopus.com/inward/record.url?scp=85058917845&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058917845&partnerID=8YFLogxK
U2 - 10.1210/en.2018-00535
DO - 10.1210/en.2018-00535
M3 - Article
C2 - 30364965
AN - SCOPUS:85058917845
SN - 0013-7227
VL - 160
SP - 38
EP - 54
JO - Endocrinology
JF - Endocrinology
IS - 1
ER -